Alvotech and Advanz Pharma add three more biosimilars to collaboration

1 day ago 1
Collaboration concept in word tag cloud

rafal_olechowski

Alvotech (NASDAQ:ALVO) and British pharmaceutical company Advanz Pharma announced Wednesday an agreement to expand their commercial collaboration to market three additional biosimilar candidates in Europe.

Biosimilars for the anti-inflammatory agent Ilaris and multiple sclerosis therapy Kesimpta, both marketed by Novartis (

Recommended For You

More Trending News

Read Entire Article